RIBOLSI, MENTORE
 Distribuzione geografica
Continente #
AS - Asia 4.670
NA - Nord America 2.737
EU - Europa 894
SA - Sud America 463
Continente sconosciuto - Info sul continente non disponibili 66
AF - Africa 62
OC - Oceania 13
Totale 8.905
Nazione #
SG - Singapore 3.249
US - Stati Uniti d'America 2.581
CN - Cina 621
IT - Italia 464
BR - Brasile 322
HK - Hong Kong 264
VN - Vietnam 240
GB - Regno Unito 118
BD - Bangladesh 115
FR - Francia 102
CA - Canada 70
DE - Germania 66
MX - Messico 49
AR - Argentina 48
IN - India 47
EC - Ecuador 28
ID - Indonesia 27
CO - Colombia 26
NL - Olanda 25
ZA - Sudafrica 22
PE - Perù 15
FI - Finlandia 14
ES - Italia 13
JP - Giappone 13
PK - Pakistan 13
RU - Federazione Russa 11
UA - Ucraina 11
VE - Venezuela 11
AU - Australia 10
PL - Polonia 10
AT - Austria 8
CZ - Repubblica Ceca 8
MY - Malesia 8
EE - Estonia 7
EG - Egitto 7
HN - Honduras 7
KZ - Kazakistan 7
PY - Paraguay 7
TR - Turchia 7
CR - Costa Rica 6
ET - Etiopia 6
IQ - Iraq 6
MA - Marocco 6
PH - Filippine 6
UZ - Uzbekistan 6
IR - Iran 5
MD - Moldavia 5
JM - Giamaica 4
RO - Romania 4
SE - Svezia 4
TH - Thailandia 4
TN - Tunisia 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
AM - Armenia 3
CL - Cile 3
DO - Repubblica Dominicana 3
NP - Nepal 3
OM - Oman 3
PT - Portogallo 3
SA - Arabia Saudita 3
SV - El Salvador 3
AO - Angola 2
AZ - Azerbaigian 2
BB - Barbados 2
BE - Belgio 2
BG - Bulgaria 2
CI - Costa d'Avorio 2
CY - Cipro 2
GA - Gabon 2
GT - Guatemala 2
HU - Ungheria 2
IE - Irlanda 2
JO - Giordania 2
KE - Kenya 2
KR - Corea 2
ML - Mali 2
NI - Nicaragua 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
UY - Uruguay 2
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
BZ - Belize 1
CG - Congo 1
CH - Svizzera 1
DM - Dominica 1
DZ - Algeria 1
IL - Israele 1
IM - Isola di Man 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LC - Santa Lucia 1
LT - Lituania 1
ME - Montenegro 1
MG - Madagascar 1
Totale 8.825
Città #
San Jose 567
Ashburn 523
Singapore 417
Rome 265
Hong Kong 254
Beijing 177
Hefei 171
Council Bluffs 135
Columbus 100
Ho Chi Minh City 97
Dallas 89
Lauterbourg 88
London 85
Boardman 83
Santa Clara 76
New York 70
Los Angeles 60
Phoenix 56
Hanoi 51
Shanghai 51
Mexico City 29
Munich 29
São Paulo 26
Milan 25
Brooklyn 21
San Francisco 20
Buffalo 19
Burlington 19
Atlanta 18
Washington 16
Seattle 15
Denver 13
Pune 13
Chicago 12
Haiphong 12
Toronto 12
Amsterdam 11
Quito 11
Bogotá 10
Frankfurt am Main 10
Johannesburg 10
West Jordan 10
Chennai 9
Orem 9
Turku 9
Warsaw 9
Curitiba 8
Da Nang 8
Guarulhos 8
Las Vegas 8
Naples 8
Rio de Janeiro 8
Secaucus 8
Biên Hòa 7
Bologna 7
Guangzhou 7
Guayaquil 7
Lima 7
Montreal 7
Thái Bình 7
Bari 6
Boston 6
Campinas 6
Catania 6
Dhaka 6
Medellín 6
Tokyo 6
Brasília 5
Chengdu 5
Hangzhou 5
Helsinki 5
Kuala Lumpur 5
Ninh Bình 5
Paris 5
Philadelphia 5
Queens 5
Ribeirão Preto 5
San José 5
Zhuhai 5
Addis Ababa 4
Belo Horizonte 4
Brno 4
Detroit 4
Florence 4
Fresno 4
Manchester 4
Messina 4
Palermo 4
Pittsburgh 4
San Juan 4
Sona 4
Stockholm 4
Tashkent 4
The Bronx 4
Thái Nguyên 4
Vienna 4
Vĩnh Tường 4
Alvorada 3
Asunción 3
Bangkok 3
Totale 4.100
Nome #
Dilated intercellular spaces of esophageal epithelium in nonerosive reflux disease patients with physiological esophageal acid exposure 247
Colonic Epithelial Permeability to Ions Is Restored after Vedolizumab Treatment and May Predict Clinical Response in Inflammatory Bowel Disease Patients 246
Applying Lyon Consensus criteria in the work‐up of patients with proton pump inhibitory‐refractory heartburn 242
Italian guidelines for the diagnosis and management of gastro-esophageal reflux disease: Joint consensus from the Italian Societies of: Gastroenterology and Endoscopy (SIGE), Neurogastroenterology and Motility (SINGEM), Hospital Gastroenterologists and Endoscopists (AIGO), Digestive Endoscopy (SIED), and General Medicine (SIMG) 241
Anti-tumor necrosis factor-alpha reverts growth hormone resistance associated with inflammatory bowel disease 237
Esophageal and Oropharyngeal Dysphagia: Clinical Recommendations From the United European Gastroenterology and European Society for Neurogastroenterology and Motility 235
Novel impedance-pH parameters are associated with proton pump inhibitor response in patients with inconclusive diagnosis of gastro-oesophageal reflux disease according to Lyon Consensus 234
Effect of oesophagitis on proximal extent of gastro-oesophageal reflux. 228
Effect of the gatekeeper reflux repair system on intra-esophageal distribution of acid reflux in gastroesophageal reflux disease patients: Relation with typical symptoms 217
Clinical impact of proton pump inhibitor response and dependence 214
Correlation between reflux burden, peristaltic function, and mucosal integrity in GERD patients 204
Association between dietary habits and fecal microbiota composition in irritable bowel syndrome patients: A pilot study 173
Achalasia, from diagnosis to treatment 158
Association between post-reflux swallow-induced peristaltic wave index and esophageal mucosal integrity in patients with GERD symptoms 150
Chicago Classification v4.0 Stratifies Acid Burden and Abnormal Impedance-pH Variables Better Than Chicago Classification v3.0 Chicago Classification v4.0 and GERD 147
The 1st EoETALY Consensus on the Diagnosis and Management of Eosinophilic Esophagitis–Current Treatment and Monitoring 144
Acid reflux episodes sensitize the esophagus to perception of weakly acidic and mixed reflux in non-erosive reflux disease patients 144
Wall Thickness Ratio—A New Magnetic Resonance Parameter—Is Associated With the Outcome of Biological Therapy in Patients With Ileal and Ileocolonic Crohn’s Disease 143
Application of Lyon Consensus criteria for GORD diagnosis: evaluation of conventional and new impedance-pH parameters 142
Breathing training on lower esophageal sphincter as a complementary treatment of gastroesophageal reflux disease (GERD): a systematic review 141
Anxiety correlates with excessive air swallowing and PPI refractoriness in patients with concomitant symptoms of GERD and functional dyspepsia 138
Dynamic contrast enhanced magnetic resonance imaging of the terminal ileum: differentiation of activity of Crohn’s disease 132
Effect of hiatal hernia on proximal oesophageal acid clearance in gastro-oesophageal reflux disease patients 130
Effect of endoscopic augmentation of the lower oesophageal sphincter (Gatekeeper reflux repair system) on intraoesophageal dynamic characteristics of acid reflux 124
Esophageal pH increments associated with post-reflux swallow-induced peristaltic waves show the occurrence and relevance of esophago-salivary reflex in clinical setting 111
Impedance baseline and reflux perception in responder and non-responder non-erosive reflux disease patients 110
Dilated intercellular spaces and acid reflux at the distal and proximal oesophagus in patients with non-erosive gastro-oesophageal reflux disease 99
Mechanisms of action of prebiotics and their effects on gastro-intestinal disorders in adults 93
Impaired colonic contractility and intestinal permeability in symptomatic uncomplicated diverticular disease 93
Palmitic acid affects intestinal epithelial barrier integrity and permeability in vitro 93
The 1st EoETALY Consensus on the Diagnosis and Management of Eosinophilic Esophagitis – Definition, Clinical Presentation and Diagnosis 89
Practice guidelines on the use of esophageal manometry – A GISMAD-SIGE-AIGO medical position statement 86
Patients With Definite and Inconclusive Evidence of Reflux According to Lyon Consensus Display Similar Motility and Esophagogastric Junction Characteristics 84
Prospective validation of reflux monitoring by impedance-pH in predicting PPI response in typical GERD 83
Psychological distress in inflammatory bowel disease 80
Impedance-High Resolution Manometry Analysis of Patients With Nonerosive Reflux Disease 79
Esophageal chest pain resembles heartburn in reflux metrics and response to proton pump inhibitor therapy 78
Nutritional status and bioelectrical phase angle assessment in adult Crohn disease patients receiving anti-TNFα therapy 78
On‐therapy impedance‐pH monitoring can efficiently characterize PPI‐refractory GERD and support treatment escalation 76
Platelet-activating factor and distinct chemokines are elevated in mucosal biopsies of erosive compared with non-erosive reflux disease patients and controls 76
Reflux pattern and role of impedance-pH variables in predicting PPI response in patients with suspected GERD-related chronic cough. 75
The Lyon Consensus: Does It Differ From the Previous Ones? 73
The Results From Up-Front Esophageal Testing Predict Proton Pump Inhibitor Response in Patients With Chronic Cough 72
Topical Protection of Esophageal Mucosa as a New Treatment of GERD 70
Esophageal motility disorders among elderly patients: An international multicenter study 68
Infliximab reverses growth hormone resistance associated with inflammatory bowel disease 68
Diagnostic delay and misdiagnosis in eosinophilic oesophagitis 65
Intra-oesophageal distribution and perception of acid reflux in patients with non-erosive gastro-oesophageal reflux disease 65
Pharmacological management of gastro-esophageal reflux disease: state of the art in 2024 63
An update of pharmacology, efficacy, and safety of vonoprazan in acid-related disorders 61
Ambulatory reflux monitoring for diagnosis of gastro-esophageal reflux disease: Update of the Porto consensus and recommendations from an international consensus group 61
The Clinical Spectrum of Gastroesophageal Reflux Disease: Facts and Fictions 60
Artificial Intelligence in the Diagnosis of Upper Gastrointestinal Diseases 60
Increased frequency and enhanced perception of reflux in non-erosive reflux disease patients non-responder to proton pump inhibitors 58
Normal values and regional differences in oesophageal impedance-pH metrics: a consensus analysis of impedance-pH studies from around the world 58
Intercellular space diameters of the oesophageal epithelium in NERD patients: head to head comparision between light and electron microscopy 57
Intra-bolus pressure and esophagogastric gradient, assessed with high-resolution manometry, are associated with acid exposure and proximal migration of refluxate 55
Baseline impedance levels and structural and functional integrity of the esophageal mucosa: is acid still the only player? 55
Presence of gas in the refluxate enhances reflux perception in non-erosive patients with physiological acid exposure of the oesophagus 55
Exploring the Complex Interplay Between Ineffective Esophageal Motility and Reflux Burden 54
Dilated intercellular space diameter as marker of reflux-related mucosal injury in children with chronic cough and gastro-oesophageal reflux disease 54
Encouraging appropriate use of proton pump inhibitors: existing initiatives and proposals for the future 53
Weak peristalsis with large breaks is associated with higher acid exposure and delayed reflux clearance in the supine position in GERD patients 53
High-resolution Manometry Findings During Solid Swallows Correlate With Delayed Reflux Clearance and Acid Exposure Time in Non-erosive Reflux Disease Patients 53
Proximal esophageal impedance baseline increases the yield of impedance‐pH and is associated with response to PPIs in chronic cough patients 53
Towards a better diagnosis of gastro esophageal reflux disease 52
New classifications of gastroesophageal reflux disease: an improvement for patient management? 52
Nutritional aspects in inflammatory bowel diseases 52
Role of Esophageal Motility, Acid Reflux, and of Acid Suppression in Nonobstructive Dysphagia 52
Relevance of Excessive Air Swallowing in GERD Patients With Concomitant Functional Dyspepsia and Poor Response to PPI Therapy 51
Classification of esophageal motor findings in gastro-esophageal reflux disease: Conclusions from an international consensus group 50
Relationship between baseline impedance levels and esophageal mucosal integrity in children with erosive and non-erosive reflux disease 50
Postreflux swallow-induced peristaltic wave index from pH-impedance monitoring associates with esophageal body motility and esophageal acid burden 50
Nonachalasic esophageal motor disorders, from diagnosis to therapy 49
Letter to the Editor: Relevance of a Correct GERD Patient Classification Before Anti-reflux Procedures 49
Advancements in the use of 24-hour impedance-pH monitoring for GERD diagnosis 48
High-resolution Manometry Determinants of Refractoriness of Reflux Symptoms to Proton Pump Inhibitor Therapy 48
Reflux characteristics triggering post-reflux swallow-induced peristaltic wave (PSPW) in patients with GERD symptoms 47
Editorial: inconclusive diagnosis of GERD: are new parameters in impedance‐pHmetry ready for clinical use? Authors' reply 47
Role of Overweight and Obesity in Gastrointestinal Disease 47
Prevalence and clinical characteristics of refractoriness to optimal proton pump inhibitor therapy in non-erosive reflux disease 47
Proximal esophageal impedance baseline increases the yield of impedance-pH monitoring for GERD diagnosis and is associated with heartburn response to PPI 46
Proton pump inhibitor resistance, the real challenge in gastro-esophageal reflux disease 45
PATIENTS WITH EXTRA-ESOPHAGEAL SYMPTOMS, COMPARED TO NERD PATIENTS WITH TYPICAL SYMPTOMS AND HEALTHY VOLUNTEERS, ARE CHARACTERIZED BY A HIGHER NUMBER OF REFLUX EPISODES AND HIGHER PROPORTION OF WEAKLY ACIDIC AND MIXED REFLUX 45
Fragmented and failed swallows on esophageal high-resolution manometry associate with abnormal reflux burden better than weak swallows 44
Exploring the association between esophageal mucosal inflammation, impaired motility, and GERD severity 43
Modern Diagnosis of Early Esophageal Cancer: From Blood Biomarkers to Advanced Endoscopy and Artificial Intelligence 43
Should we have to include transcutaneous neuromodulation in the therapeutic GERD armamentarium? 43
Role of Mixed Reflux and Hypomotility with Delayed Reflux Clearance in Patients with Non-cardiac Chest Pain 43
Letter: the potential link between oesophageal hypervigilance, visceral anxiety, increased swallow rate and oesophageal mucosal integrity 42
Editorial: Lyon consensus metrics—towards personalised diagnosis of non‐erosive reflux disease: Authors' reply 41
Post-reflux swallow-induced peristaltic wave index and mean nocturnal baseline impedance predict PPI response in GERD patients with extra esophageal symptoms 41
Understanding the relationship between esophageal motor disorders and reflux disease 41
Letter: is wireless oesophageal pH monitoring the best technique to evaluate night‐time reflux? 39
Maintenance of remission with infliximab in inflammatory bowel disease: Efficacy and safety long-term follow-up 39
Oesophageal mucosal intercellular space diameter and reflux pattern in childhood erosive and non-erosive reflux disease 39
Regional oesophageal sensitivity to acid and weakly acidic reflux in patients with non-erosive reflux disease 38
Short duration of acid exposure sensitizes the esophagus to perception of weakly acidic and mixed reflux in non-erosive reflux disease (NERD) patients 37
Measurement of acid exposure of proximal esophagus: a better tool for diagnosing non-erosive reflux disease 36
Letter: should we have to include baclofen in the GORD therapy armamentarium? 31
Totale 8.905
Categoria #
all - tutte 46.878
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.878


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202281 0 0 0 0 0 2 0 2 0 3 0 74
2022/202333 1 0 0 2 0 1 0 2 0 0 27 0
2023/2024331 5 35 42 23 18 137 3 27 3 17 15 6
2024/20253.468 39 24 117 26 42 75 62 16 230 208 1.127 1.502
2025/20263.833 355 199 298 586 171 162 889 205 288 293 199 188
2026/20271.157 64 309 298 486 0 0 0 0 0 0 0 0
Totale 8.905